Imamura Kotaro, Kawakami Norito, Furukawa Toshi A, Matsuyama Yutaka, Shimazu Akihito, Kasai Kiyoto
Department of Mental Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Departments of Health Promotion and Human Behavior and of Clinical Epidemiology, Graduate School of Medicine/School of Public Health, Kyoto University, Kyoto, Japan.
BMJ Open. 2015 May 12;5(5):e007590. doi: 10.1136/bmjopen-2015-007590.
The aim of this study is to examine the effects of an internet-based cognitive behavioural therapy (iCBT) program on decreasing the risk of major depressive episodes (MDEs) among workers employed in a private corporate group in Japan, using a randomised controlled trial design.
All of the workers in a corporate group (n=20,000) will be recruited through an invitation email. Participants who fulfil the inclusion criteria will be randomly allocated to intervention or control groups (planned N=4050 for each group). They will be allowed to complete the six lessons of the iCBT program within 10 weeks after the baseline survey. Those in the control group will receive the same iCBT after 12 months. The program includes several CBT skills: self-monitoring, cognitive restructuring, assertiveness, problem-solving and relaxation. The primary outcome measure is no new onset of MDE (using Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)/DSM-5 criteria) during the 12-month follow-up. Assessment will use the web version of the WHO Composite International Diagnostic Interview V.3.0 depression section.
The Research Ethics Review Board of Graduate School of Medicine, the University of Tokyo (No. 3083-(2)), approved the study procedures.
The study protocol is registered at the UMIN Clinical Trials Registry (UMIN-CTR; ID=UMIN000014146).
本研究旨在采用随机对照试验设计,检验基于互联网的认知行为疗法(iCBT)项目对降低日本一家私营企业集团员工中重度抑郁发作(MDE)风险的效果。
将通过邀请邮件招募一家企业集团的所有员工(n = 20000)。符合纳入标准的参与者将被随机分配到干预组或对照组(每组计划N = 4050)。他们将被允许在基线调查后的10周内完成iCBT项目的六节课。对照组将在12个月后接受相同的iCBT。该项目包括几种认知行为疗法技能:自我监测、认知重构、自信训练、问题解决和放松。主要结局指标是在12个月随访期间无MDE新发病例(使用《精神障碍诊断与统计手册》第四版,修订本(DSM-IV-TR)/DSM-5标准)。评估将使用世界卫生组织综合国际诊断访谈V.3.0抑郁症部分的网络版。
东京大学医学研究生院研究伦理审查委员会(第3083-(2)号)批准了研究程序。
该研究方案已在UMIN临床试验注册中心注册(UMIN-CTR;ID = UMIN000014146)。